🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

As a synthetic biologist I get asked a lot if you could ever release an engineered microbe in the EU. This paper gives an important account of efforts to do so by a team at Cambridge, and describes the legal labyrinth that makes it possible yet impossible. academic.oup.com/synbio/advance…

BREAKING: The first orally administered #microbiota-based therapeutic has been approved by the U.S. FDA. Learn more: bit.ly/3Aye4IO

Thrilled to share TWO accomplishments, a quick 🧵about the first: my first-author paper covering the bulk of my PhD is out today in Nature Chemical Biology! link here: nature.com/articles/s4158… (1/3)

In this Down to Business article, Maria Lluch-Senar shares her story of co-founding the company Pulmobiotics SL to clinically translate engineered bacteria for the treatment of respiratory diseases - all the way from fundamental science to the pre-IND nature.com/articles/s4422…

What are the challenges of translating engineered bacteria as live therapeutics to the clinic? Read an honest account by Maria, CSO and co-founder of Pulmobiotics SL

Amazing paper, congrats Maria !

Our spin off Pulmobiotics SL engineers bacteria for the treatment of respiratory diseases Here, Maria decribes MycoChassis — an attenuated bacterium strain obtained by genome engineering of Mycoplasma pneumoniae - and challenges on the road to its clinical translation

1/ The development of #smartbiologics has been stuck in the same paradigm - until now. A new startup Pearl Bio is rewriting the language of life with its genetically recoded organism #GRO. Read more about this fascinating technology: forbes.com/sites/johncumb…

PORTFOLIO NEWS/ It's our pleasure to announce a significant $7M pre-Series A investment in OneChain Therapeutics. The company is just days away from dosing its first patient, FIH is imminent. It may pave the way for many patients to benefit from this innovative treatment.

The #SevereAsthmaIndex, developed by Copenhagen Institute for Futures Studies, assesses what impacts a country’s ability to manage severe asthma and calls upon healthcare professionals to implement long-term strategies and make severe asthma care a priority.

A paper in Nature Biotechnology introduces wildDISCO, a new approach for whole-body immunolabeling, optical clearing and imaging in mice. go.nature.com/46LcfXT

Finalmente!!! We got It!

Very interesting and promising strategy! nature.com/articles/s4158…

A very interesting study for those that plan to remodel chassis ! academic.oup.com/nar/article/51…

Next generation synthetic memory via intercepting recombinase function doi.org/10.1038/s41467…

Excited to share - EcORep! Now you can simply electroporate a PCR product into E. coli and let the linear DNA replicate orthogonally in the cell. EcORep can be used to evolve proteins rapidly and continuously! science.org/doi/10.1126/sc…

⭐ #EAEBarcelona presenta la III Edición de #Top10MujeresEmprendedoras de Catalunya, una iniciativa para poner en valor el talento emprendedor femenino del territorio y empoderar su visión y liderazgo a dando soluciones útiles para la sociedad. ¡Conoce las 10 finalistas! 👇

🗣️ Trencant la bretxa de gènere en l’àmbit directiu Demà celebrem el Dia de la Dona i la Nena en la Ciència, i és per aquest motiu, que avui compartim reflexions sobre la importància de la igualtat de gènere.

Conoce a 12 científicas que trabajan cada día para avanzar en la investigación contra el cáncer. Descubre sus historias: view.genially.com/67a07a9051e107…

#InvestigandoEnCáncer